Actively Recruiting
Intestinal Microbiota in Stem Cell Transplant Transplant Admission
Led by Henry Ford Health System · Updated on 2026-02-24
255
Participants Needed
1
Research Sites
417 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In this prospective study, the primary objective will be to investigate the association between the use of antibiotics administered during the admission period of Stem cell transplant (SCT) and the rate of overall change in microbiota composition across adjacent samples in time.
CONDITIONS
Official Title
Intestinal Microbiota in Stem Cell Transplant Transplant Admission
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18-80 years
- Patients undergoing allogenic or autologous stem cell transplant for malignant hematological conditions or bone marrow failure
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Henry Ford Health System
Detroit, Michigan, United States, 48202
Actively Recruiting
Research Team
S
shatha farhan, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here